| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchi | 4 | 2017 | 100 | 0.770 |
Why?
|
| Asthma | 12 | 2008 | 743 | 0.760 |
Why?
|
| Critical Illness | 6 | 2015 | 588 | 0.660 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 10 | 2021 | 594 | 0.630 |
Why?
|
| Bronchoscopy | 8 | 2018 | 155 | 0.610 |
Why?
|
| Critical Care | 6 | 2014 | 647 | 0.610 |
Why?
|
| Granulation Tissue | 1 | 2017 | 12 | 0.590 |
Why?
|
| Hemoptysis | 1 | 2017 | 22 | 0.580 |
Why?
|
| Tracheotomy | 1 | 2017 | 35 | 0.580 |
Why?
|
| Sclerotherapy | 1 | 2017 | 40 | 0.570 |
Why?
|
| Pregnancy Complications | 4 | 2015 | 503 | 0.570 |
Why?
|
| Varicose Veins | 1 | 2017 | 28 | 0.570 |
Why?
|
| Pulmonary Atelectasis | 1 | 2017 | 14 | 0.560 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 39 | 0.550 |
Why?
|
| Respiration, Artificial | 7 | 2017 | 453 | 0.540 |
Why?
|
| Airway Obstruction | 2 | 2017 | 165 | 0.510 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2022 | 195 | 0.450 |
Why?
|
| Tracheal Stenosis | 1 | 2014 | 30 | 0.450 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 41 | 0.450 |
Why?
|
| Anesthesia, General | 1 | 2014 | 111 | 0.430 |
Why?
|
| Haemophilus influenzae | 2 | 2003 | 130 | 0.400 |
Why?
|
| Intubation, Intratracheal | 5 | 2017 | 289 | 0.390 |
Why?
|
| Veterans | 4 | 2023 | 1710 | 0.360 |
Why?
|
| Helium | 2 | 2005 | 10 | 0.310 |
Why?
|
| Middle Aged | 31 | 2018 | 25640 | 0.300 |
Why?
|
| Stents | 1 | 2014 | 864 | 0.290 |
Why?
|
| Thoracic Wall | 1 | 2007 | 38 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2030 | 0.280 |
Why?
|
| Bronchodilator Agents | 2 | 2005 | 153 | 0.270 |
Why?
|
| Humans | 62 | 2023 | 122296 | 0.270 |
Why?
|
| Sepsis | 4 | 2013 | 472 | 0.260 |
Why?
|
| Female | 46 | 2023 | 64883 | 0.260 |
Why?
|
| Aerosol Propellants | 1 | 2005 | 2 | 0.260 |
Why?
|
| Albuterol | 1 | 2005 | 52 | 0.250 |
Why?
|
| Withholding Treatment | 1 | 2005 | 67 | 0.240 |
Why?
|
| Haemophilus Infections | 2 | 2003 | 92 | 0.240 |
Why?
|
| Oxygen | 2 | 2005 | 549 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2007 | 339 | 0.230 |
Why?
|
| Terminal Care | 1 | 2005 | 114 | 0.230 |
Why?
|
| Lung | 4 | 2018 | 1476 | 0.220 |
Why?
|
| Adult | 30 | 2018 | 28733 | 0.220 |
Why?
|
| Laryngeal Diseases | 2 | 2002 | 30 | 0.220 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 1615 | 0.210 |
Why?
|
| Hospital Mortality | 4 | 2021 | 996 | 0.210 |
Why?
|
| Respiratory Tract Infections | 2 | 2003 | 263 | 0.210 |
Why?
|
| Respiration Disorders | 1 | 2002 | 31 | 0.210 |
Why?
|
| Health Status Indicators | 1 | 2003 | 117 | 0.210 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2015 | 103 | 0.210 |
Why?
|
| Connective Tissue Diseases | 1 | 2002 | 29 | 0.210 |
Why?
|
| Male | 34 | 2018 | 59522 | 0.200 |
Why?
|
| Rheumatic Diseases | 1 | 2002 | 66 | 0.200 |
Why?
|
| Bronchitis, Chronic | 1 | 2001 | 18 | 0.190 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 112 | 0.190 |
Why?
|
| Carrier State | 1 | 2001 | 76 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 147 | 0.190 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 382 | 0.190 |
Why?
|
| Citrulline | 2 | 2013 | 84 | 0.180 |
Why?
|
| Virus Diseases | 1 | 2003 | 280 | 0.180 |
Why?
|
| Bronchitis | 2 | 2012 | 34 | 0.170 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 581 | 0.170 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 160 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 98 | 0.170 |
Why?
|
| Receptors, Leukotriene | 2 | 2012 | 6 | 0.170 |
Why?
|
| Case-Control Studies | 8 | 2022 | 3229 | 0.170 |
Why?
|
| Cesarean Section | 2 | 2014 | 380 | 0.170 |
Why?
|
| Electric Injuries | 1 | 1999 | 4 | 0.160 |
Why?
|
| Aged | 19 | 2023 | 18785 | 0.160 |
Why?
|
| Bronchial Neoplasms | 1 | 2018 | 16 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2021 | 364 | 0.150 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 21 | 0.150 |
Why?
|
| Algorithms | 2 | 2023 | 1575 | 0.150 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1227 | 0.150 |
Why?
|
| Shock, Septic | 2 | 2009 | 148 | 0.150 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2018 | 62 | 0.150 |
Why?
|
| Electrocoagulation | 1 | 2017 | 37 | 0.150 |
Why?
|
| Intensive Care Units | 5 | 2015 | 475 | 0.150 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2017 | 31 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2018 | 90 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2003 | 1463 | 0.140 |
Why?
|
| Energy Metabolism | 2 | 2013 | 747 | 0.140 |
Why?
|
| Respiratory Function Tests | 5 | 2018 | 194 | 0.140 |
Why?
|
| Fatal Outcome | 2 | 2017 | 356 | 0.140 |
Why?
|
| Pregnancy | 8 | 2018 | 7092 | 0.140 |
Why?
|
| Amniotic Fluid | 1 | 2017 | 147 | 0.140 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2018 | 147 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 141 | 0.130 |
Why?
|
| Clinical Protocols | 2 | 2014 | 237 | 0.130 |
Why?
|
| Retrospective Studies | 12 | 2022 | 15853 | 0.130 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 2817 | 0.130 |
Why?
|
| Chemokines, CXC | 2 | 2007 | 39 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 33 | 0.120 |
Why?
|
| Tracheostomy | 1 | 2017 | 189 | 0.120 |
Why?
|
| Placenta, Retained | 1 | 2014 | 11 | 0.120 |
Why?
|
| Endosonography | 1 | 2015 | 82 | 0.120 |
Why?
|
| Spirometry | 3 | 2018 | 74 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2009 | 438 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2015 | 206 | 0.120 |
Why?
|
| Laryngeal Masks | 1 | 2014 | 19 | 0.120 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2014 | 30 | 0.110 |
Why?
|
| Prospective Studies | 9 | 2013 | 5963 | 0.110 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 141 | 0.110 |
Why?
|
| Plasma Exchange | 1 | 2014 | 83 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2017 | 907 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 285 | 0.110 |
Why?
|
| Acute Disease | 7 | 2007 | 1090 | 0.110 |
Why?
|
| Tracheitis | 1 | 2012 | 14 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2022 | 408 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2015 | 376 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2014 | 182 | 0.110 |
Why?
|
| Mycosis Fungoides | 1 | 2012 | 14 | 0.110 |
Why?
|
| Enterocytes | 1 | 2013 | 70 | 0.100 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 253 | 0.100 |
Why?
|
| Status Asthmaticus | 1 | 2012 | 20 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2013 | 76 | 0.100 |
Why?
|
| Placenta Accreta | 1 | 2014 | 144 | 0.100 |
Why?
|
| Glutamine | 1 | 2013 | 194 | 0.100 |
Why?
|
| Sputum | 2 | 2003 | 110 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1204 | 0.100 |
Why?
|
| Rhinovirus | 2 | 2010 | 59 | 0.100 |
Why?
|
| Disease Management | 1 | 2015 | 511 | 0.100 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 36 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2014 | 379 | 0.090 |
Why?
|
| Respiratory Therapy | 1 | 2011 | 22 | 0.090 |
Why?
|
| Rest | 1 | 2011 | 59 | 0.090 |
Why?
|
| Life Support Care | 1 | 2011 | 45 | 0.090 |
Why?
|
| Airway Management | 1 | 2011 | 66 | 0.090 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 71 | 0.090 |
Why?
|
| Picornaviridae Infections | 1 | 2010 | 48 | 0.090 |
Why?
|
| Physical Examination | 1 | 2011 | 163 | 0.090 |
Why?
|
| Shock | 1 | 2011 | 89 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2010 | 114 | 0.090 |
Why?
|
| Glucose | 2 | 2011 | 875 | 0.080 |
Why?
|
| Prevalence | 4 | 2011 | 2371 | 0.080 |
Why?
|
| Proteins | 2 | 2011 | 1043 | 0.080 |
Why?
|
| Respiratory Sounds | 1 | 2008 | 68 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2010 | 348 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 274 | 0.080 |
Why?
|
| Prenatal Care | 1 | 2011 | 340 | 0.080 |
Why?
|
| India | 2 | 2005 | 218 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2826 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2007 | 89 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 474 | 0.070 |
Why?
|
| Biopsy | 4 | 2007 | 1246 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 143 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2008 | 99 | 0.070 |
Why?
|
| Arginine | 1 | 2009 | 302 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 469 | 0.070 |
Why?
|
| Elastin | 1 | 2007 | 31 | 0.070 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2011 | 312 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 144 | 0.070 |
Why?
|
| Heart Injuries | 2 | 1999 | 46 | 0.070 |
Why?
|
| Emphysema | 1 | 2007 | 65 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 475 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2007 | 170 | 0.070 |
Why?
|
| Risk Factors | 5 | 2022 | 9902 | 0.070 |
Why?
|
| Forced Expiratory Volume | 3 | 2018 | 169 | 0.070 |
Why?
|
| Smoking | 2 | 2012 | 1028 | 0.060 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2005 | 9 | 0.060 |
Why?
|
| Neutrophil Activation | 1 | 2005 | 16 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 609 | 0.060 |
Why?
|
| Lung Volume Measurements | 1 | 2005 | 67 | 0.060 |
Why?
|
| Vocal Cords | 1 | 2006 | 63 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 151 | 0.060 |
Why?
|
| Biological Availability | 1 | 2005 | 128 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2005 | 82 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2005 | 78 | 0.060 |
Why?
|
| Prognosis | 3 | 2011 | 4488 | 0.060 |
Why?
|
| Leucine | 3 | 2013 | 309 | 0.060 |
Why?
|
| Multiple Organ Failure | 2 | 2005 | 140 | 0.060 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2010 | 40 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 177 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2004 | 21 | 0.060 |
Why?
|
| Adolescent | 7 | 2018 | 18940 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2004 | 51 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2004 | 83 | 0.060 |
Why?
|
| Leukocytes | 1 | 2005 | 204 | 0.060 |
Why?
|
| Saskatchewan | 1 | 2023 | 2 | 0.060 |
Why?
|
| Up-Regulation | 4 | 2011 | 873 | 0.060 |
Why?
|
| Narration | 1 | 2023 | 29 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 606 | 0.060 |
Why?
|
| Length of Stay | 2 | 2014 | 1273 | 0.060 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2003 | 9 | 0.060 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2003 | 15 | 0.060 |
Why?
|
| Respiratory Mucosa | 3 | 2012 | 91 | 0.050 |
Why?
|
| Professional Practice Gaps | 1 | 2023 | 15 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2003 | 65 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2023 | 70 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2003 | 39 | 0.050 |
Why?
|
| Ipratropium | 1 | 2002 | 7 | 0.050 |
Why?
|
| Acetates | 1 | 2003 | 72 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1679 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2007 | 941 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2010 | 0.050 |
Why?
|
| Young Adult | 4 | 2018 | 8760 | 0.050 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2002 | 38 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2003 | 209 | 0.050 |
Why?
|
| Safety | 1 | 2003 | 217 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 111 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2021 | 21 | 0.050 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2001 | 28 | 0.050 |
Why?
|
| Viruses | 1 | 2003 | 123 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2023 | 154 | 0.050 |
Why?
|
| Indoles | 1 | 2003 | 177 | 0.050 |
Why?
|
| Ribotyping | 1 | 2001 | 45 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2003 | 169 | 0.050 |
Why?
|
| Larynx | 1 | 2002 | 67 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2023 | 184 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 812 | 0.050 |
Why?
|
| United States | 5 | 2023 | 10487 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2023 | 321 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 461 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2021 | 95 | 0.050 |
Why?
|
| Logistic Models | 2 | 2003 | 1772 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 168 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 145 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2013 | 12045 | 0.040 |
Why?
|
| Postural Balance | 1 | 2021 | 125 | 0.040 |
Why?
|
| Edetic Acid | 1 | 2000 | 23 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 758 | 0.040 |
Why?
|
| Cations | 1 | 2000 | 38 | 0.040 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2000 | 14 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 43 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2001 | 480 | 0.040 |
Why?
|
| Carbon Isotopes | 2 | 2011 | 272 | 0.040 |
Why?
|
| Anesthetics, Intravenous | 1 | 2000 | 47 | 0.040 |
Why?
|
| Education, Medical | 1 | 2023 | 285 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 252 | 0.040 |
Why?
|
| Propofol | 1 | 2000 | 44 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 418 | 0.040 |
Why?
|
| Burns, Electric | 1 | 1999 | 4 | 0.040 |
Why?
|
| Neutrophils | 3 | 2007 | 371 | 0.040 |
Why?
|
| Lightning Injuries | 1 | 1999 | 2 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1407 | 0.040 |
Why?
|
| Veterans Health | 1 | 2021 | 172 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 1022 | 0.040 |
Why?
|
| Body Weight | 1 | 2003 | 963 | 0.040 |
Why?
|
| Compartment Syndromes | 1 | 1999 | 28 | 0.040 |
Why?
|
| Vibration | 2 | 2008 | 31 | 0.040 |
Why?
|
| Equipment Design | 3 | 2008 | 596 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 75 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 1579 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2014 | 4643 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2013 | 1568 | 0.040 |
Why?
|
| Term Birth | 1 | 2017 | 32 | 0.040 |
Why?
|
| Triage | 1 | 1999 | 141 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 1592 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2008 | 92 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 487 | 0.040 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1520 | 0.040 |
Why?
|
| Pneumocystis | 1 | 1997 | 11 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1997 | 12 | 0.040 |
Why?
|
| Benzenesulfonates | 1 | 1997 | 11 | 0.040 |
Why?
|
| Emergencies | 1 | 1999 | 175 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6291 | 0.040 |
Why?
|
| Cell Count | 1 | 2017 | 251 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2000 | 232 | 0.040 |
Why?
|
| Angioedema | 1 | 1997 | 22 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 1997 | 28 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2023 | 972 | 0.030 |
Why?
|
| Resuscitation | 1 | 1999 | 240 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1997 | 77 | 0.030 |
Why?
|
| Phenotype | 2 | 2007 | 4151 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3448 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2011 | 539 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 2997 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1997 | 210 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 261 | 0.030 |
Why?
|
| Heart Failure | 1 | 2008 | 2125 | 0.030 |
Why?
|
| Time Factors | 3 | 2003 | 6182 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 111 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 254 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 93 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 398 | 0.030 |
Why?
|
| Contrast Media | 1 | 1997 | 459 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 140 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5013 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2007 | 517 | 0.030 |
Why?
|
| Nitrogen Isotopes | 1 | 2013 | 54 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 122 | 0.030 |
Why?
|
| APACHE | 1 | 2013 | 52 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 100 | 0.030 |
Why?
|
| Splanchnic Circulation | 1 | 2013 | 52 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 147 | 0.030 |
Why?
|
| Bronchoscopes | 1 | 1992 | 5 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2014 | 176 | 0.030 |
Why?
|
| Placebos | 1 | 2013 | 239 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 4366 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2005 | 8096 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 1993 | 131 | 0.020 |
Why?
|
| Candidiasis | 1 | 2012 | 129 | 0.020 |
Why?
|
| Radioactive Tracers | 1 | 2011 | 20 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1710 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2796 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 145 | 0.020 |
Why?
|
| Laryngoscopy | 2 | 2006 | 149 | 0.020 |
Why?
|
| Radiography | 2 | 2008 | 804 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 357 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 139 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 157 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2010 | 147 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2010 | 181 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1370 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1871 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2008 | 22 | 0.020 |
Why?
|
| Paracentesis | 1 | 2008 | 17 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 680 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 768 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1993 | 963 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 508 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 1678 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2010 | 404 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1993 | 710 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1315 | 0.020 |
Why?
|
| Cause of Death | 2 | 2003 | 451 | 0.020 |
Why?
|
| Pneumonia | 1 | 2010 | 325 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2007 | 86 | 0.020 |
Why?
|
| Glottis | 1 | 2006 | 31 | 0.020 |
Why?
|
| Inflammation | 2 | 2003 | 1392 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 3301 | 0.020 |
Why?
|
| RNA Probes | 1 | 2005 | 30 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Trachea | 2 | 1997 | 197 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2007 | 102 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2005 | 38 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2005 | 47 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 107 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 212 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 268 | 0.020 |
Why?
|
| Neutropenia | 1 | 2007 | 202 | 0.020 |
Why?
|
| Mast Cells | 1 | 2005 | 75 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 680 | 0.020 |
Why?
|
| Child | 3 | 2018 | 24064 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 333 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 17546 | 0.010 |
Why?
|
| Eosinophils | 1 | 2005 | 120 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 3074 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Group II Phospholipases A2 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 230 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2003 | 35 | 0.010 |
Why?
|
| Keto Acids | 1 | 2003 | 55 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2003 | 46 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 390 | 0.010 |
Why?
|
| Aerosols | 1 | 2002 | 66 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 4282 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2003 | 155 | 0.010 |
Why?
|
| Macrophages | 1 | 2005 | 611 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2002 | 304 | 0.010 |
Why?
|
| Gestational Age | 1 | 2005 | 1115 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 33721 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2000 | 72 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 121 | 0.010 |
Why?
|
| Emergency Service, Hospital | 2 | 1997 | 1060 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 1298 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1468 | 0.010 |
Why?
|
| Coronaviridae | 1 | 1998 | 4 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 421 | 0.010 |
Why?
|
| Urban Health | 1 | 1998 | 71 | 0.010 |
Why?
|
| Orthomyxoviridae | 1 | 1998 | 50 | 0.010 |
Why?
|
| Incidence | 2 | 1997 | 3018 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 668 | 0.010 |
Why?
|
| Rhinoscleroma | 1 | 1997 | 4 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1998 | 492 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1997 | 37 | 0.010 |
Why?
|
| Suction | 1 | 1997 | 57 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1997 | 237 | 0.010 |
Why?
|
| Vocal Cord Paralysis | 1 | 1997 | 68 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 1296 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1283 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1095 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1997 | 234 | 0.010 |
Why?
|
| Cost Savings | 1 | 1993 | 69 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1993 | 122 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1997 | 384 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1993 | 147 | 0.010 |
Why?
|
| Kidney | 1 | 2000 | 1340 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 1131 | 0.010 |
Why?
|
| Heart Atria | 1 | 1993 | 307 | 0.010 |
Why?
|
| Texas | 1 | 1998 | 3528 | 0.010 |
Why?
|
| Hospitalization | 1 | 1997 | 1727 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 1993 | 1244 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1997 | 13777 | 0.000 |
Why?
|